Mental Health

Health Sarah Owermohle

Your dog is probably on Prozac. Experts say that says more about the American mental health crisis than pets

The Readout Meghana Keshavan

STAT Plus: Lawmakers want to add more Chinese biotechs to defense list

Health tech Mario Aguilar

STAT Plus: Otsuka’s digital treatment for depression cleared by FDA, as pharma tries to crack tricky market

Adam's Take Adam Feuerstein

STAT Plus: A preview of Intra-Cellular Therapies’ depression drug, and sizing up the MASH opportunity

Biotech Adam Feuerstein

STAT Plus: Acadia’s Nuplazid fails as treatment for schizophrenia in Phase 3 study

Letters to the editor Torie Bosch

STAT readers on new CDC Covid guidelines, weight loss drugs and mental health, and new psychiatric meds

First Opinion Amit Etkin

STAT Plus: It’s time to rethink everything about our approach to psychiatric drug development

Health tech Mario Aguilar

STAT Plus: With Meta’s backing, Headspace launches into VR

Health tech Mario Aguilar

STAT Plus: Medicare is a tricky market for telehealth companies. Why is Talkspace betting on it?

Biotech Damian Garde

STAT Plus: A ‘renaissance in neuroscience’ could deliver a fresh crop of psychiatric medicines

First Opinion Anand Kumar

Palliative psychiatry offers a new path for some people with serious mental illness

Health tech Mario Aguilar

STAT Plus: DarioHealth acquires Twill, hoping it’s a shortcut to profitability

First Opinion Jody Dushay and Karen S. Greenberg

The complicated connections between weight loss drugs and mental health

First Opinion Eric Reinhart

Moving from crisis response to crisis prevention in U.S. mental health systems

Health Elaine Chen

STAT Plus: Can Wegovy treat depression as well as obesity? New research looks to GLP-1 drugs for mental illnesses

Health Grace Rubenstein

Amid a dire nationwide therapist shortage, could lay counselors help close the gap?

Exclusive Rachel Cohrs Zhang

STAT Plus: Congress’ negotiations over doc pay, health centers fell apart ahead of spending extension

The Readout Meghana Keshavan

STAT Plus: Novartis reportedly decides to pass on Cytokinetics

Health Mario Aguilar

STAT Plus: Accolade beats analyst estimates, Teladoc’s optimism, and more JPM health tech news

First Opinion Janelle Goodwill

Addressing the Black youth suicide crisis requires a new approach to licensing clinical social workers

Adam Feuerstein, Allison DeAngelis, Damian Garde, and Matthew Herper

STAT Plus: This is the TLDR of JPM Day 1

First Opinion Andrew Popper

Insurance companies are forcing psychiatrists like me to stop accepting their coverage

Health Gina Ryder

Cardiac psychologists are pushing to protect heart patients’ often-overlooked mental health

Morning Rounds Annalisa Merelli

STAT Plus: Morning Rounds: Can you take GLP-1 drugs during pregnancy?

First Opinion Sarah Darghouth

Clients bring politics into the therapy room. Here’s what that means for the therapist

First Opinion Podcast Torie Bosch

Listen: What we take for granted after 30 years of Prozac

First Opinion Phyllis Vine

What Rosalynn Carter understood about mental health

First Opinion Peter D. Kramer

What antidepressants are saying 30 years after the publication of ‘Listening to Prozac’

First Opinion Podcast Torie Bosch

Listen: The true costs of mediocre insurance plans for medical students